Buscar
Mostrando ítems 1-10 de 1149
ANTIVIRAL DRUG REVIEW A GUIDE TO CLINICIANS
(Universidade Federal de Goiás, 2017)
Advances in the development of entry inhibitors for sialic-acid-targeting viruses
Over the past decades, several antiviral drugs have been developed to treat a range
of infections. Yet the number of treatable viral infections is still limited, and resistance
to current drug regimens is an ever-growing ...
Antivirals for COVID-19: A critical review
No specific drugs have been approved for coronavirus disease 2019 (COVID-19) to date as the development of
antivirals usually requires time. Therefore, assessment and use of currently available antiviral drugs is critical ...
Repurposing Annita® drug against ZIKV infection on Human Placenta and Cervix cells
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2019)
Propolis antiviral and immunomodulatory activity: A review and perspectives for COVID-19 treatment
(2021-01-01)
Objectives Viral outbreaks are a frequent concern for humans. A great variety of drugs has been used to treat viral diseases, which are not always safe and effective and may induce adverse effects, indicating the need for ...
A roadmap to engineering antiviral natural products synthesis in microbes
Natural products continue to be the inspirations for us to
discover and acquire new drugs. The seemingly unstoppable
viruses have kept records high to threaten human health and
well-being. The diversity and complexity ...
Plant-derived antivirals against hepatitis c virus infection
(Biomed Central Ltd, 2018-02-13)
Hepatitis C virus (HCV) infection is a worldwide public health burden and it is estimated that 185 million people are or have previously been infected worldwide. There is no effective vaccine for prevention of HCV infection; ...
GA-Hecate antiviral properties on HCV whole cycle represent a new antiviral class and open the door for the development of broad spectrum antivirals
(Nature Publishing Group, 2018-09-25)
In recent years, synthetic peptides have been considered promising targets for drug development that possess low side-effects, are cost-effective and are susceptible to rational design. Hecate was initially described as a ...